Discover how the Liver-Chip S1 is transforming drug development and toxicology prediction. This white paper highlights key findings from our 2022 Communications Medicine study, where the Liver-Chip achieved 87% sensitivity and 100% specificity in detecting drug-induced liver injury across 870 chips.
What’s inside:
- How the Liver-Chip S1 outperforms traditional models by delivering human-relevant insights into drug safety.
- The potential $3B+ annual productivity impact of integrating the Liver-Chip S1 into R&D workflows.
- Regulatory milestones, including Liver-Chip S1 acceptance into the FDA ISTAND program.
- Advancing drug testing precision with the Liver-Chip R1, which addresses non-specific binding.
Explore the next generation of preclinical safety testing. Download the white paper now to see how Emulate Organ-on-a-Chip technology is reshaping toxicology prediction and accelerating safer therapeutics to market.